-
Mashup Score: 6FDA Grants Fast Track Designation to Eneboparatide for Treatment of Patients With Hypoparathyroidism - 6 day(s) ago
Currently, the treatment is being evaluated in the phase 3 CALYPSO study to further prove the safety and efficacy in patients with hypoparathyroidism.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
Venture capital investments in women’s health are growing, with innovation looking beyond traditional avenues.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 4US Preventive Services Task Force Recommends Breast Cancer Screenings Begin at Age 40 - 6 day(s) ago
The screenings should be conducted every other year, beginning at age 40 and continuing through age 74, according to the new recommendation.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 3
Novo Nordisk and Eli Lilly have spoken out against the use of their GLP-1 medications for cosmetic weight loss, emphasizing the proper use of their medications.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 7Preventing RSV in Adults: Current Vaccination Options - 8 day(s) ago
Panelists compare the currently available RSV vaccines for adults, considering their target populations, dosing, and administration to prevent RSV infection.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Our newest Peer Exchange series, centered around the pharmacist’s role in respiratory syncytial virus (RSV) prevention, is now officially live! Explore insights on understanding RSV susceptibility in patients, associated health consequences, and more: https://t.co/4IDtOL3fC3. https://t.co/YnVBICRE4i
-
-
Mashup Score: 8Identifying Food Allergies vs Food Intolerances: Pharmacists Can Play a Critical Role in Education - 8 day(s) ago
Pharmacists can help patients distinguish between food allergies and intolerances, as well as facilitate access to life-saving medications and preventative care.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1FDA Grants Full Approval to Tisotumab Vedotin-tftv for Recurrent, Metastatic Cervical Cancer - 8 day(s) ago
Tisotumab vedotin-tftv is the first antibody-drug conjugate to demonstrate positive overall survival data in patients with previously treated recurrent or metastatic cancer.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2
Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0FDA Approves Fidanacogene Elaparvovec-dzkt as One-Time Gene Therapy for Adults With Hemophilia B - 8 day(s) ago
The 1-time treatment may be a better alternative for patients who don’t want to undergo frequent doses of standard of care intravenous factor IX infusions.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 1Recreational Cannabis Legalization Associated with Decreases in Alcohol, E-Cigarette Use - 9 day(s) ago
Retail sales were associated with lower e-cigarette use, although recreational legalization also increased the frequency of cannabis use among adolescents.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
The FDA granted a fast track designation to eneboparatide for the treatment of hypoparathyroidism. The treatment had demonstrated positive effects in a phase 2 clinical trial, and it is continuing to be evaluated in a phase 3 trial. Learn more: https://t.co/xOh4004fy5